From: Endocannabinoid signalling in the blood of patients with schizophrenia
Patient Number | Anandamide levels in the blood during the acute phase of schizophrenic illness (pmol/ml) | Anandamide levels in the blood during remission of schizophrenic illness (pmol/ml) | BPRS (and CGI) Scores Acute Remission |
---|---|---|---|
1 | 11.7 | 59 (5) | |
2 | 7.3 | 64 (5) | |
3 | 8.4 | 4.4 | 68 (6) 25 (1) |
4 | 8.2 | 48 (4) | |
5 | 6.3 | 6.2 | 60 (5) 20 (1) |
6 | 5.3 | 2.2 | 66 (6) 29 (2) |
7 | 7.7 | 4.1 | 56 (5) 26 (1) |
8 | 6.7 | 2.5 | 70 (6) 29 (2) |
9 | 7.5 | 55 (4) | |
10 | 9.7 | 57 (4) | |
11 | 8.7 | 56 (4) | |
12 | 6.0 | 52 (5) | |
7.79 ± 0.50 (P = 4.5 × 10 -8 vs. Control) | 3.88 ± 0.72 (P = 0.16 vs. Control) |